Literature DB >> 15121365

Punctal occlusion in the management of chronic Stevens-Johnson syndrome.

Minako Kaido1, Eiki Goto, Murat Dogru, Kazuo Tsubota.   

Abstract

PURPOSE: To evaluate the effect of lacrimal punctal occlusion in the management of the ocular surface disease in chronic Stevens-Johnson syndrome.
DESIGN: Retrospective noncomparative case series. PARTICIPANTS: Thirty-one eyes of 18 patients with chronic Stevens-Johnson syndrome seen at the Department of Ophthalmology of the Tokyo Dental College were studied. INTERVENTION: Patients' lacrimal puncta were occluded by cauterization or with punctal plugs. MAIN OUTCOME MEASURES: The effect of lacrimal punctal occlusion was evaluated by changes in subjective symptoms, best-corrected visual acuity (VA), Schirmer test, tear clearance test, and ocular surface double vital staining before and after punctal occlusion.
RESULTS: After lacrimal punctal occlusion, symptomatic improvement was observed in 19 eyes (61.3%). The mean logarithmic VA showed significant improvement from -0.64+/-0.87 to -0.52+/-0.86 (P<0.05). The Schirmer I test results before punctal occlusion yielded a mean score of 7.4+/-8.7 mm, which changed to 10.2+/-8.3 mm after punctal occlusion. The mean preocclusion and postocclusion tear clearance values were 7.5+/-6.6 times and 4.9+/-4.8 times, respectively. The Rose Bengal staining score decreased from 4.7+/-2.8 to 2.7+/-2.2 points (P<0.05), and the fluorescein staining score decreased from 5.0+/-2.3 to 2.2+/-2.5 points (P<0.05), respectively.
CONCLUSIONS: Concurrent improvements in subjective symptoms, vital staining scores, and VA point to the favorable effects of lacrimal punctal occlusion for the ocular surface health in chronic Stevens-Johnson syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121365     DOI: 10.1016/j.ophtha.2003.09.034

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  The relation of functional visual acuity measurement methodology to tear functions and ocular surface status.

Authors:  Minako Kaido; Reiko Ishida; Murat Dogru; Kazuo Tsubota
Journal:  Jpn J Ophthalmol       Date:  2011-06-30       Impact factor: 2.447

2.  The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.

Authors:  M Victoria De Rojas; John K G Dart; Valerie P J Saw
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

Review 3.  [Mucous membrane pemphigoid with ocular involvement. Part II: therapy].

Authors:  T Meyer-ter-Vehn; E Schmidt; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-04       Impact factor: 1.059

4.  Interleukin-17 in various ocular surface inflammatory diseases.

Authors:  Min Ho Kang; Mee Kum Kim; Hyun Joo Lee; Hyeon Il Lee; Won Ryang Wee; Jin Hak Lee
Journal:  J Korean Med Sci       Date:  2011-06-20       Impact factor: 2.153

5.  The challenge of dry eye diagnosis.

Authors:  Giacomo Savini; Pinita Prabhawasat; Takashi Kojima; Martin Grueterich; Edgar Espana; Eiki Goto
Journal:  Clin Ophthalmol       Date:  2008-03

6.  Medial blepharosynechioplasty: a new surgical concept for severe dry eye.

Authors:  Tsugihisa Sasaki; Taeko Ota; Youko Ookura; Kazuhisa Sugiyama
Journal:  Clin Ophthalmol       Date:  2012-06-22

7.  Bilateral conjunctival retention cysts in the aftermath of Stevens-Johnson syndrome.

Authors:  Gurdeep Singh; Revathi Rajaraman; Anita Raghavan; Manikandan Palanisamy
Journal:  Indian J Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 1.848

8.  Long-Term Outcome of Treatment with Topical Corticosteroids for Severe Dry Eye Associated with Sjögren's Syndrome.

Authors:  Hyun Ho Jung; Yong Sok Ji; Mi Sun Sung; Kyung Keun Kim; Kyung Chul Yoon
Journal:  Chonnam Med J       Date:  2015-04-14

Review 9.  Acute and Chronic Management of Ocular Disease in Stevens Johnson Syndrome/Toxic Epidermal Necrolysis in the USA.

Authors:  Derek Metcalfe; Omer Iqbal; James Chodosh; Charles S Bouchard; Hajirah N Saeed
Journal:  Front Med (Lausanne)       Date:  2021-07-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.